📈
📈 Business
Novo Nordisk Sues Eli Lilly Over Misleading Weight-Loss Drug Ads
Danish pharma giant Novo Nordisk has filed a lawsuit against US rival Eli Lilly, alleging "false and materially misleading" advertising for its weight-loss drugs Zepbound and Mounjaro. Novo Nordisk claims Eli Lilly deliberately used outdated clinical trials that compared its highest doses against lower doses of Novo Nordisk's medicines to make them appear more effective. The legal battle centres on the lucrative GLP-1 weight-loss drug market.
🏥 Health
Novo Nordisk sues Eli Lilly over misleading Zepbound vs Wegovy weight-loss comparison
The Independent World · 2d ago
🏥 Health
Who benefits from classifying obesity as a disease? Pharma firms lead the push
STAT News · 14d ago
📈 Business
Ozempic-maker Novo Nordisk sues Eli Lilly over misleading obesity drug ads
BBC Business · 2d ago
🏥 Health
Who benefits from classifying obesity as a disease? Pharma firms lead the push
STAT News · 14d ago
📈 Business
Ozempic-maker Novo Nordisk sues Eli Lilly over misleading obesity drug ads
BBC Business · 2d ago
Comments
No comments yet
Comments
No comments yet — be the first to weigh in 👇
No comments yet. Be the first!